Tag: Diabetes: Type II
Short Sleep Duration Linked to Increased Risk for Developing T2D
Association between habitual short sleep duration and increased risk for T2D persisted for individuals following healthy diet
Markers of Systemic Inflammation May Aid Diabetes Risk Prediction
Findings seen for high-sensitivity C-reactive protein, monocyte-to-high-density lipoprotein ratio
FDA Says Yogurt Makers Can Make ‘Qualified’ Claims About T2D Prevention
'Qualified health claim' does not meet the more rigorous 'significant scientific agreement' standard
Type 2 Diabetes Remission Maintained After RYGB Despite Weight Regain
Overall rate of continued diabetes remission higher for those undergoing RYGB versus sleeve gastrectomy
Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Kidney Stone Risk
Findings seen compared with glucagon-like peptide 1 receptor agonists or dipeptidyl peptidase 4 inhibitors
Exercise Intensity, Duration Can Affect CKD Risk in Obesity, Type 2 Diabetes
Inverse link seen for total MVPA, MVPA accumulated in bouts of ≥10 minutes with progression to CKD in overweight/obese adults with T2D
GLP1 Agonists Reduce Major Adverse Liver Outcomes in Chronic Liver Disease
For patients with chronic liver disease and type 2 diabetes, GLP1 agonist initiators associated with lower risk for major adverse liver outcomes
Risk for CKD, CVD Lower for Adults With Evidence of Type 2 Diabetes Remission
Significantly lower risks of chronic kidney disease, composite cardiovascular disease measure seen for those with any remission
Type 2 Diabetes Remission Likely With Weight Loss After Diagnosis
Increased likelihood of diabetes remission and reduced risk for returning to hyperglycemia seen with weight loss in year after diagnosis
Healthful Plant-Based Diet May Lower Risk for Type 2 Diabetes
Association with lower risk for T2DM partially mediated by lower BMI, lower waist circumference, and lower HbA1c, triglycerides